DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates
- PMID: 17287056
- DOI: 10.1016/j.vaccine.2007.01.011
DNA vaccines expressing glycoprotein complex II antigens gM and gN elicited neutralizing antibodies against multiple human cytomegalovirus (HCMV) isolates
Abstract
Human cytomegalovirus (HCMV) glycoprotein complex II (gcII) consists of two glycoproteins, gM and gN. Although gcII specific IgG purified from HCMV positive patient sera can neutralize HCMV, there has been no report describing the generation of virus-neutralizing antibodies by immunization with individual recombinant gM or gN antigens. In the current study, gM and gN antigens were expressed by the mammalian expression vector pJW4303 and used as DNA vaccines to determine the immunogenicity of these proteins. Sera from mice or rabbits immunized with individual or combinations of gM and gN DNA vaccines contained gM and gN specific antibodies as confirmed by ELISA and Western blot analyses. The combined gM and gN antigens induced the strongest antibody responses that recognized both gM and gcII complex while gM DNA vaccine alone could only elicit antibody specific for gM antigen. When given alone, the gN DNA vaccine did not induce detectable gcII specific antibody even though in vitro gN expression was confirmed by the formation of gM/gN complex in FSK cells using a gN-specific monoclonal antibody 14-16A. The neutralizing antibody titer of anti-gM/gN sera (1:128) was higher than that of anti-gM sera (1:32) against the autologous virus, HCMV AD169. Heterologous HCMV strains including Towne and Davis could also be neutralized by the anti-gM/gN antisera. Our data supported the rationale for the use of the HCMV gM/gN protein complex as protective antigens for subunit based HCMV vaccine development. DNA vaccination is an effective approach to express the gM/gN antigen complex in vivo without the need to express and purify these highly insoluble and structurally complicated antigens.
Similar articles
-
[Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].Wei Sheng Wu Xue Bao. 2007 Aug;47(4):677-81. Wei Sheng Wu Xue Bao. 2007. PMID: 17944371 Chinese.
-
Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.Vaccine. 2014 Jun 24;32(30):3796-804. doi: 10.1016/j.vaccine.2014.05.004. Epub 2014 May 14. Vaccine. 2014. PMID: 24837507
-
Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.Virology. 2000 Mar 1;268(1):49-55. doi: 10.1006/viro.1999.0142. Virology. 2000. PMID: 10683326
-
The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.Vaccine. 2012 Nov 19;30(49):6980-90. doi: 10.1016/j.vaccine.2012.09.056. Epub 2012 Oct 3. Vaccine. 2012. PMID: 23041121 Review.
-
Genomic variants among human cytomegalovirus (HCMV) clinical isolates: the glycoprotein n (gN) paradigm.Hum Immunol. 2004 May;65(5):387-94. doi: 10.1016/j.humimm.2004.02.023. Hum Immunol. 2004. PMID: 15172436 Review.
Cited by
-
A Novel Non-Replication-Competent Cytomegalovirus Capsid Mutant Vaccine Strategy Is Effective in Reducing Congenital Infection.J Virol. 2016 Aug 12;90(17):7902-19. doi: 10.1128/JVI.00283-16. Print 2016 Sep 1. J Virol. 2016. PMID: 27334585 Free PMC article.
-
Human Cytomegalovirus Primary Infection and Reactivation: Insights From Virion-Carried Molecules.Front Microbiol. 2020 Jul 14;11:1511. doi: 10.3389/fmicb.2020.01511. eCollection 2020. Front Microbiol. 2020. PMID: 32765441 Free PMC article. Review.
-
Rat and human cytomegalovirus ORF116 encodes a virion envelope glycoprotein required for infectivity.Virology. 2021 May;557:23-33. doi: 10.1016/j.virol.2020.12.014. Epub 2021 Feb 9. Virology. 2021. PMID: 33601113 Free PMC article.
-
Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge.Virol Sin. 2013 Jun;28(3):174-82. doi: 10.1007/s12250-013-3330-9. Epub 2013 May 24. Virol Sin. 2013. PMID: 23715998 Free PMC article.
-
DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.Hum Vaccin Immunother. 2013 Oct;9(10):2120-32. doi: 10.4161/hv.25750. Epub 2013 Jul 25. Hum Vaccin Immunother. 2013. PMID: 24051429 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources